Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS +57.89%·Rev n/aQ1 23EPS +18.18%·Rev n/aQ4 22EPS +33.33%·Rev n/aQ3 22EPS +68.42%·Rev n/a⚠ consensus missing

Aurinia Pharmaceuticals Inc. AUPH

Jamie Harrell — Investor Relations

Peter Greenleaf — Chief Executive Officer

Joe Miller — Chief Financial Officer

+4.2%1d on move date+4.5% vs SPY3d−3.8%5d−6.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AUPH calls or request research access.

More AUPH calls Browse calls Request research access